Hangzhou Tigermed Consulting is a contract research organisation that helps pharmaceutical and biotechnology companies develop new medicines. It provides clinical trial services, including trial design and management, data management, statistical analysis, regulatory affairs support and medical writing. Its customers are drug developers and medical device makers that outsource parts of their research work. The company is based in Hangzhou, China, and serves clients in China and other markets.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 3347, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #727 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendFair
67/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-8.1%
From 52-week high-31.2%
MomentumFair
66/100
Typical recent returns for this exchange.
See the numbers →
3-month return-0.4%
6-month return-10.5%
12-month, skipping last month11.4%
Stability (higher is calmer)Fair
55/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)52.3%
Worst drawdown, 1 year (smaller is calmer)-46.6%
LiquidityStrong
89/100
Trades actively.
See the numbers →
Avg daily value traded65.46M HKD
Zero-volume days0.0%
IncomeWeak
31/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.4%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 28.12 – 57.00Daily closes, split-adjusted
Signals
50-day average42.48
200-day average41.36
Golden/death cross (60d)Golden, 14 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.52
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
2 bullish · 1 neutral · 9 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
41.91
Bearish
EMA 10
41.53
Bearish
SMA 20
43.90
Bearish
EMA 20
42.63
Bearish
SMA 50
42.48
Bearish
EMA 50
42.13
Bearish
SMA 100
38.87
Bearish
EMA 100
40.98
Bearish
SMA 200
41.36
Bearish
EMA 200
40.66
Bearish
Oscillators (daily)
RSI (14)
33.81
Neutral
MACD (12, 26)
-0.87
Bearish
Momentum (12)
-16.15
Bearish
Stochastic %K (14)
3.47
Bullish
Williams %R (14)
-96.53
Bullish
CCI (20)
-157.3
Bullish
Pivot points (classic, last session)
S3
32.33
S2
34.99
S1
36.49
Pivot
39.15
R1
40.65
R2
43.31
R3
44.81
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.14 HKD
Yield on today's price
0.38%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.1447
0.3245
0.6237
0.5680
0.6156
0.5796
0.3619
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
